NervGen logo

NervGen Employee Directory

Biotechnology ResearchBritish Columbia, Canada11-50 Employees

NervGen Pharma Corp. is a clinical-stage biotechnology company focused on neuroreparative therapeutics for spinal cord injury and other neurotraumatic and neurologic conditions. Its lead candidate, NVG-291, is delivered by subcutaneous administration and has been evaluated in the Phase 1b/2a CONNECT SCI trial in individuals with chronic SCI (1 to 10 years post-injury), where it demonstrated durable improvements in function, independence, and quality of life. The company is advancing NVG-300 as a next-generation candidate and is preparing for a Phase 3 trial in chronic SCI, while being based in Vancouver, British Columbia, and operating with a small to mid-sized team.

NervGen has regulatory designations for SCI, including FDA Fast Track and EMA Orphan Drug status. In April 2026, the company appointed Keith Vendola as Chief Financial Officer, reflecting ongoing governance activity and continued engagement with the broader scientific and investor communities through industry events.

Find NervGen employees' phone numbers or email addresses

NervGen Global Highlights

Location
Employees

North America
14

Minus sign iconPlus sign icon
  • Canada
    7
  • United States Of America
    7

NervGen's Leadership

  • Chief Executive Officer at NervGen
    A. R.
    Chief Executive Officer
  • Chief Financial Officer at NervGen
    B. A.
    Chief Financial Officer
  • Co-Founder at NervGen
    H. P.
    Co-Founder
  • Executive Assistant To President & Chief Executive Officer And Chairman at NervGen
    B. R.
    Executive Assistant To President & Chief Executive Officer And Chairman
  • Director, Co-Founder at NervGen
    H. P.
    Director, Co-Founder

NervGen Employee Metrics

100%
50%
0%
2026
2025
  • Entrepreneurship
  • Biotechnology
  • Business
  • Sales
  • Accounting
  • Other
  • Community & Social Services
  • Business Development

Contact profiles from NervGen

Name
Title
Contact
Location
Last Update
  • Chief Executive Officer at NervGen
    A. R.
    Chief Executive Officer
    Canada
    Jun 04, 2026
  • Chief Financial Officer at NervGen
    B. A.
    Chief Financial Officer
    Jun 04, 2026
  • Co-Founder at NervGen
    H. P.
    Co-Founder
    Canada, British Columbia
    Aug 01, 2026
  • Executive Assistant To President & Chief Executive Officer And Chairman at NervGen
    B. R.
    Executive Assistant To President & Chief Executive Officer And Chairman
    Canada, Ontario
    Aug 01, 2025
  • Director, Co-Founder at NervGen
    H. P.
    Director, Co-Founder
    Canada, British Columbia
    Jul 06, 2026

Frequently Asked Questions

What is NervGen known for?

Minus sign iconPlus sign icon
NervGen was founded in 2018 and operates in the Biotechnology Research industry. Explore NervGen's company overview page for more information.

What is NervGen's most common email format?

Minus sign iconPlus sign icon
NervGen employees' email format typically follows the pattern of FLast@nervgen.com. Trying to find reliable and up-to-date employee contact data? Find more NervGen email formats with LeadIQ.

How many employees does NervGen have currently?

Minus sign iconPlus sign icon
NervGen has approximately 15 employees as of August 2026. These team members are located across 1 continents, including North America.

Who are NervGen's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, NervGen's key employees include:

  • Chief Executive Officer: A. R.
  • Chief Financial Officer: B. A.
  • Co-Founder: H. P.
  • Executive Assistant To President & Chief Executive Officer And Chairman: B. R.
  • Director, Co-Founder: H. P.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.